Literature DB >> 925936

Digoxin bioavailability: evaluation of a generic tablet and proposed FDA guidelines.

W G Kramer, A J Kolibash, M S Bathala, J A Visconti, R P Lewis, R H Reuning.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 925936     DOI: 10.1002/jps.2600661216

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


× No keyword cloud information.
  3 in total

1.  Generalization of distribution--free confidence intervals for bioavailability ratios.

Authors:  V W Steinijans; E Diletti
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

2.  Statistical analysis of bioavailability studies: parametric and nonparametric confidence intervals.

Authors:  V W Steinijans; E Diletti
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

3.  A standard approach to compiling clinical pharmacokinetic data.

Authors:  L B Sheiner; L Z Benet; L A Pagliaro
Journal:  J Pharmacokinet Biopharm       Date:  1981-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.